All Articles

As Flowers Foods preps its Q2 results amid a plummeting stock price, the bakery giant's strategic pivot towards health trends and fiscal discipline faces a critical test.

Optiv unveils Agentic Security Operations, a leap beyond traditional MDR. By fusing agentic AI with Google and Wiz, it promises a proactive, not reactive, future.

Focal Systems' new AI module scans forgotten inventory above shelves, helping retailers recover millions in lost value and dramatically slash labor costs.

A new survey reveals 99% of bankers face intense competition, with AI and stablecoins threatening to upend the financial system as we know it.

Caitlin Clark and Wilson unveil their third basketball line, a collection that showcases her evolution from star player to product co-creator and brand architect.

A new partnership uses smartphone AI to turn everyday movement into a vital sign, aiming to predict falls, manage chronic illness, and remake home healthcare.

Fintech lender Lower is betting millions on a 2% grant to help buyers overcome the down payment hurdle. Is this a sustainable market disruption or a new risk?

A new leaderboard on DefiLlama finally lets traders see how well market makers perform, adding a crucial new layer of data for judging a token's health.

An abandoned 1940s lakeside property is now an award-winning eco-luxury hotel, setting a new standard for sustainable tourism in Lane County.

Phoenix Children's appoints Dr. Joshua Koch to a novel 'Hospital Based In Chief' role, a strategic move to manage growth and integrate complex patient care.

Lifeward's pilot program with Ottobock Care isn't just a deal; it’s a strategic blueprint for scaling advanced medical tech in a new era of reimbursement.

Hult's five-year AMBA reaccreditation is more than an award; it's a validation of a model built for resilience, diversity, and real-world outcomes.

An Oklahoma AI tool predicted an election outcome with near-perfect accuracy, but a public miss revealed a critical flaw, offering a lesson for all industries.

As Ascentage Pharma preps its mid-year report, we look beyond the balance sheet at the strategic plays and clinical trials fueling its global oncology ambitions.

With a unique process for pristine graphene, HydroGraph heads to an elite investor conference, signaling a pivotal shift from R&D to industrial scale.

Marex's strategic investment in Digital Prime Technologies isn't just a deal; it's a blueprint for bringing Wall Street's rigor to digital asset lending.

Expedition Therapeutics lands a huge Series B and starts a pivotal trial for a drug that could finally target the root cause of COPD for millions.

AB InBev's new global campaign isn't just marketing. It's a strategic play backed by strong financials and data showing beer's resilient dominance.

The largest wealth transfer in history meets a revolution in human longevity. A new breed of financial firm is betting your medical data is the key to it all.

Sharp Canada's new BP80C series isn't just a printer. It's an AI-driven, fortress-secure production hub designed to bring high-value print jobs back in-house.